Title:
プロゲステロン受容体アンタゴニスト剤形
Document Type and Number:
Japanese Patent JP6486900
Kind Code:
B2
Abstract:
The invention is directed to a pharmaceutical composition comprising a progesterone receptor antagonist namely (11β,17β)-17-Hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one at the dosage of about 0.5 to 5 mg and more particularly 2 mg. Additionally, the invention is directed to the use of the novel pharmaceutical composition for treatment of and/or prophylaxis of gynaecological diseases, such as fibroids of the uterus (myomas, uterine leiomyoma), endometriosis or excessive menstrual bleeds, and method for obtaining such composition and oral dosage form.
More Like This:
Inventors:
Barbara Schutt
Marx-Hirat Schulze-Moskau
Andreas Kaiser
Marx-Hirat Schulze-Moskau
Andreas Kaiser
Application Number:
JP2016506943A
Publication Date:
March 20, 2019
Filing Date:
April 09, 2014
Export Citation:
Assignee:
Bayer Pharma Actien Gezelshaft
International Classes:
A61K31/57; A61P5/36; A61P15/00; A61P35/00
Domestic Patent References:
| JP2012533575A |
Other References:
J. Med. Chem., 2000, Vol.43, No.26, pp.5010-5016
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe
Previous Patent: 組成物、その製造、及び、食器洗い組成物としての、又は食器洗い組成物...
Next Patent: THROWAWAY SLIPPERS AND METHOD FOR MANUFACTURE THEREOF
Next Patent: THROWAWAY SLIPPERS AND METHOD FOR MANUFACTURE THEREOF